by Barry Jaruzelski, John Loehr, and Richard Holman
The early stages of innovation can be challenging. But Booz & Company’s annual study of R&D spending reveals that successful innovators bring clarity to a process often described as fuzzy and vague.
In this issue
A Strategist’s Guide to Personalized Medicine, Overcoming the Global Innovation Trade-Off, The Thought Leader Interview: William J. O’Rourke, and More
Breakthroughs in pharmaceutical innovation are poised to change the prevailing business model of the industry — with dramatic effects on healthcare costs and practice.